Inventor

Paolo Pevarello

Inventor

Pavia, IT

Overview

1993–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 43 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%

C07DHeterocyclic compounds27%

A61KPreparations for medical, dental or toiletry purposes24%

C07CAcyclic or carbocyclic compounds9%

A61NElectrotherapy4%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%

PatentTitleYear

10,669,267Substituted N-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide and N-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide derivatives P2X7 receptor antagonists2020 10,280,176Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors2019 10,167,281Substituted thiazole or oxazole P2X7 receptor antagonists2019 9,718,812'Substituted thiazole or oxazole P2X7 receptor antagonists'2017 9,637,497'Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors'2017 9,464,090'Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors'2016 9,447,029'Fluorinated arylalkylaminocarboxamide derivatives'2016 9,012,487'Bicyclo-pyrazoles active as kinase inhibitors'2015 8,981,089'Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors'2015 8,785,448'Substituted pyrrolo-pyrazole derivatives as kinase inhibitors'2014 8,563,550'Imidazolothiadiazoles for use as protein kinase inhibitors'2013 8,557,845'Substituted pyrrolo-pyrazole derivatives as kinase inhibitors'2013 8,557,857'Substituted pyrrolo-pyrazole derivatives as kinase inhibitors'2013 8,541,429'Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors'2013 8,481,585'Substituted pyrrolo-pyrazole derivatives as kinase inhibitors'2013 8,084,027'Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic'2011 7,482,354'Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors'2009 7,407,971'Substituted pyrrolo-pyrazole derivatives as kinase inhibitors'2008 RE040259'Alpha-aminoamide derivatives useful as analgesic agents'2008 7,037,929'2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents'2006 7,034,049'3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents'2006 6,863,647'2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents'2005 6,784,198'Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents'2004 6,716,856'4,5,6,7-tetrahydroindazole derivatives as antitumor agents'2004 6,486,322'Azaindole derivatives, process for their preparation, and their use as antitumor agents'2002 6,455,559'Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents'2002 6,414,013'Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention'2002 6,387,900'3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents'2002 6,335,342'Azaindole derivatives, process for their preparation, and their use as antitumor agents'2002 6,323,240'4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity'2001 6,306,903'Alpha-aminoamide derivatives useful as analgesic agents'2001 6,303,819'Substituted 2-benzylamino-2-phenyl-acetamide compounds'2001 6,218,418'3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents'2001 6,133,302'5-(3-Phenyl-3-oxo-propyl)-1H-tetrazole derivatives'2000 6,114,365'Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents'2000 6,048,896'4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity'2000 5,945,454'2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives'1999 5,912,242'N-(4-substituted-benzyl)-2-aminolactam derivatives'1999 5,502,079'N-phenylalkyl substituted .alpha.-amino carboxamide derivatives and process for their preparation'1996 5,449,692'Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation'1995 5,446,066'Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation'1995 5,391,577'N-phenylalkyl substituted .alpha.-amino carboxamide derivatives and process for their preparation'1995 5,236,957'N-phenylalkyl substituted .alpha.-amino carboxamide derivatives and process for their preparation'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–2019Based in Pavia, IT· patent location history

1999–2006Patents assigned to PHARMACIA & UPJOHN SPA (12)· patent assignee history

2008–2011Based in Madrid, ES· patent location history

2009–2019Patents assigned to NERVIANO MEDICAL SCIENCES SRL (12)· patent assignee history

2011–2016Patents assigned to PEVARELLO PAOLO (10)· patent assignee history

2013–2015Patents assigned to FANCELLI DANIELE (7)· patent assignee history

2013–2015Patents assigned to BRASCA MARIA GABRIELLA (6)· patent assignee history

2013–2020Based in Bresso, IT· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
NERVIANO MEDICAL SCIENCES SRL	12	2009–2019
PHARMACIA & UPJOHN SPA	12	1999–2006
PEVARELLO PAOLOself	10	2011–2016
FANCELLI DANIELE	7	2013–2015
BRASCA MARIA GABRIELLA	6	2013–2015

Locations

Location	Patents	Span
Pavia, IT	37	1993–2019
Bresso, IT	4	2013–2020
Madrid, ES	2	2008–2011